| Issue Date | Title | Author(s) |
| 2020-11-03 | Circulating tumour cell clusters: Insights into tumour dissemination and metastasis. | Herath, S; Razavi Bazaz, S; Monkman, J; Ebrahimi Warkiani, M; Richard, D; O'Byrne, K; Kulasinghe, A |
| 2022 | Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update. | Kapeleris, J; Ebrahimi Warkiani, M; Kulasinghe, A; Vela, I; Kenny, L; Ladwa, R; O'Byrne, K; Punyadeera, C |
| 2023 | Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. | Sadeghirad, H; Liu, N; Monkman, J; Ma, N; Cheikh, BB; Jhaveri, N; Tan, CW; Warkiani, ME; Adams, MN; Nguyen, Q; Ladwa, R; Braubach, O; O'Byrne, K; Davis, M; Hughes, BGM; Kulasinghe, A |
| 2017-02-15 | Enrichment of circulating head and neck tumour cells using spiral microfluidic technology | Kulasinghe, A; Tran, THP; Blick, T; O'Byrne, K; Thompson, EW; Warkiani, ME; Nelson, C; Kenny, L; Punyadeera, C |
| 2020-10 | Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Oleary, C; Vela, I; Leo, P; Sternes, P; O'Byrne, K; Punyadeera, C |
| 2020-11-27 | High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). | Monkman, J; Taheri, T; Ebrahimi Warkiani, M; O'Leary, C; Ladwa, R; Richard, D; O'Byrne, K; Kulasinghe, A |
| 2022 | IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. | Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Teo, SM; Rodrigues Rossi, G; McCulloch, TR; Nalos, M; Raei, M; Razavi, A; Ghasemian, R; Gheibi, M; Roozbeh, F; Sly, PD; Spann, KM; Chew, KY; Zhu, Y; Xia, Y; Wells, TJ; Senegaglia, AC; Kuniyoshi, CL; Franck, CL; Dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, TM; Kuan, WS; Jee, Y; Iredell, J; O'Byrne, K; Fraser, JF; Davis, MJ; Belz, GT; Warkiani, ME; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, KR; Tang, B |
| 2023-02 | Immunotherapeutic targets in non-small cell lung cancer. | Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2019-03-18 | Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets. | Kulasinghe, A; Kapeleris, J; Cooper, C; Warkiani, ME; O'Byrne, K; Punyadeera, C |
| 2018-08-14 | The prognostic role of circulating tumor cells (CTCs) in lung cancer | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Vela, I; Kenny, L; O'Byrne, K; Punyadeera, C |
| 2022-07 | Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. | Kapeleris, J; Müller Bark, J; Ranjit, S; Irwin, D; Hartel, G; Warkiani, ME; Leo, P; O'Leary, C; Ladwa, R; O'Byrne, K; Hughes, BGM; Punyadeera, C |
| 2016-09-13 | Short term ex-vivo expansion of circulating head and neck tumour cells. | Kulasinghe, A; Perry, C; Warkiani, ME; Blick, T; Davies, A; O'Byrne, K; Thompson, EW; Nelson, CC; Vela, I; Punyadeera, C |
| 2020-01 | The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies. | Sadeghi Rad, H; Bazaz, SR; Monkman, J; Ebrahimi Warkiani, M; Rezaei, N; O'Byrne, K; Kulasinghe, A |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021 | The Role of Circulating Biomarkers in Lung Cancer. | Herath, S; Sadeghi Rad, H; Radfar, P; Ladwa, R; Warkiani, M; O'Byrne, K; Kulasinghe, A |
| 2020-06-15 | The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells. | Kulasinghe, A; Lim, Y; Kapeleris, J; Warkiani, M; O'Byrne, K; Punyadeera, C |
| 2021-01-01 | Understanding the tumor microenvironment for effective immunotherapy. | Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A |
| 2022 | Understanding the tumor microenvironment in head and neck squamous cell carcinoma. | Rad, HS; Shiravand, Y; Radfar, P; Ladwa, R; Perry, C; Han, X; Warkiani, ME; Adams, MN; Hughes, BG; O'Byrne, K; Kulasinghe, A |
| 2024 | Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies placental dysfunction signatures. | Stylianou, N; Sebina, I; Matigian, N; Monkman, J; Doehler, H; Röhl, J; Allenby, M; Nam, A; Pan, L; Rockstroh, A; Sadeghirad, H; Chung, K; Sobanski, T; O'Byrne, K; Almeida, ACSF; Rebutini, PZ; Machado-Souza, C; Stonoga, ETS; Warkiani, ME; Salomon, C; Short, K; McClements, L; de Noronha, L; Huang, R; Belz, GT; Souza-Fonseca-Guimaraes, F; Clifton, V; Kulasinghe, A |
